Cardiology

Key opinion leaders in the cardiometabolic space describe the importance of the introduction of SGLT2 inhibitors for heart failure treatment based on 2022 guidelines.

A University of Michigan-led analysis of NHANES data provides insight into the increases in prevalence of food insecurity among patients with cardiovascular disease in the US across racial and ethnic groups.

NAFLD resulted in a number of other negative outcomes, including sleep disturbance, cardiovascular disease, significant hepatic fibrosis, and advanced hepatic fibrosis.

Research finds potential benefits to using apremilast for plaque psoriasis patients.

"Collectively, this work highlights and supports chronotype as a potential risk factor related to type 2 diabetes and cardiovascular disease risk," investigators wrote.

Our latest cardiology case report features a person in his mid-80s presenting to the hospital with lightheadedness and rectal bleeding for one day, with ongoing tenesmus. Check out ECG and determine the correct diagnosis!

SGLT2 inhibitors, ARNIs, and MRAs were associated with a significant decrease in hospital admission for heart failure.

New evidence from a Mount Sinai study suggested that consistent lack of sleep has negative effects on immune stem cells and increases the risk of inflammatory disorders and heart disease.

A new study encompassing data from more than 48,000,000 patients provides insight into the risk of major arterial and cerebrovascular diseases up to 49 weeks following initial COVID-19 diagnosis.

This risk also increased with age and was amplified in patients with HCV compared to patients without HCV.

Short and long nighttime sleep duration, along with daytime napping, were associated with a moderate increase in risk of cardiovascular diseases.

Dr. Thosani discusses the convergence of technology and physiology, treatment advancements, and virtual medicine capabilities in the field of heart arrhythmia.

A reduction in aspirin use was associated with significantly less bleeding and health care use, without an increase in thrombotic outcomes.

High CPAP adherence also resulted in a significant protective effect on the 30-day readmission for beneficiaries with heart failure.

Announced on September 15 by Edwards Lifesciences Corporation, the PASCAL Precision transcatheter valve repair system has received approval for transcatheter edge-to-edge repair in patients with degenerative mitral regurgitation.

In this episode of Don’t Miss a Beat, hosts Stephen Greene, MD, and Muthiah Vaduganathan, MD, MPH, provide a recap of the European Society of Cardiology Congress 2022. This recap begins with a discussion on the results of the phase 3 DELIVER trial, in which Vaduganathan served as an investigator, the ADVOR trial, and REVIVED.

Short-term treatment with rosuvastatin was not linked to changes in insulin resistance markers in a cohort of children with familial hypercholesterolemia.

On September 1, Bayer announced the US FDA had approved a label update for finerenone (Kerendia), which received initial approval in July 2021 for chronic kidney disease associated with type 2 diabetes, to include cardiovascular outcomes data from the FIGARO-DKD trial.

These reductions were only observed in short-term follow-up and were driven by early reductions within 12 months of telemedicine intervention.

An analysis of the NutriNet-Santé cohort provides insight into the apparent increase in cardiovascular disease risk associated with consumption of artificial sweeteners.

A study presented at EASD 22 comparing 600k patients with type 2 diabetes against 1.2 million controls suggests a diagnosis of T2D prior to turning 40 was associated with a more than 5-fold increase in risk of mortality, heart failure hospitalization, and coronary heart disease.

Young adults with a high cumulative alcohol burden had up to 25% higher risk of incident AF.

A new study from the AHA's Hypertension Scientific Sessions provides an overview of the potential population-level benefit of behavior modification, including adherence to a DASH diet, on CVD events and mortality among patients with stage 1 hypertension.

The mean LDL-C level among US young adults was 104.9 mg/dL In 2015-2020.

Announced by Boston Scientific on September 6, the label for the WATCHMAN FLX LAAC device now includes a 45-day DAPT option as an alternative to the 45-day postprocedural OAC plus aspirin regimen for patients with nonvalvular atrial fibrillation.